The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cough Suppressant Drugs Market Research Report 2025
Synopsis
Cough Suppressant, also known as cAntitussives, are widely used to relieve the symptoms of cough. They are substances which suppress the coughing itself. Examples are codeine, pholcodine, dextromethorphan, noscapine, and butamirate.
The global Cough Suppressant Drugs market was valued at US$ 972.8 million in 2023 and is anticipated to reach US$ 1159.9 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cough Suppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cough Suppressant Drugs.
Report Scope
The Cough Suppressant Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cough Suppressant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cough Suppressant Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo Company
Vernalis
Tris Pharma
Pfizer
Acella Pharmaceuticals
GlaxoSmithKline
Segment by Type
Dry Cough
Wet Cough
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cough Suppressant Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cough Suppressant, also known as cAntitussives, are widely used to relieve the symptoms of cough. They are substances which suppress the coughing itself. Examples are codeine, pholcodine, dextromethorphan, noscapine, and butamirate.
The global Cough Suppressant Drugs market was valued at US$ 972.8 million in 2023 and is anticipated to reach US$ 1159.9 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cough Suppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cough Suppressant Drugs.
Report Scope
The Cough Suppressant Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cough Suppressant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cough Suppressant Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo Company
Vernalis
Tris Pharma
Pfizer
Acella Pharmaceuticals
GlaxoSmithKline
Segment by Type
Dry Cough
Wet Cough
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cough Suppressant Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cough Suppressant Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dry Cough
1.2.3 Wet Cough
1.3 Market by Application
1.3.1 Global Cough Suppressant Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cough Suppressant Drugs Market Perspective (2019-2030)
2.2 Cough Suppressant Drugs Growth Trends by Region
2.2.1 Global Cough Suppressant Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cough Suppressant Drugs Historic Market Size by Region (2019-2024)
2.2.3 Cough Suppressant Drugs Forecasted Market Size by Region (2025-2030)
2.3 Cough Suppressant Drugs Market Dynamics
2.3.1 Cough Suppressant Drugs Industry Trends
2.3.2 Cough Suppressant Drugs Market Drivers
2.3.3 Cough Suppressant Drugs Market Challenges
2.3.4 Cough Suppressant Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cough Suppressant Drugs Players by Revenue
3.1.1 Global Top Cough Suppressant Drugs Players by Revenue (2019-2024)
3.1.2 Global Cough Suppressant Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Cough Suppressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cough Suppressant Drugs Revenue
3.4 Global Cough Suppressant Drugs Market Concentration Ratio
3.4.1 Global Cough Suppressant Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cough Suppressant Drugs Revenue in 2023
3.5 Cough Suppressant Drugs Key Players Head office and Area Served
3.6 Key Players Cough Suppressant Drugs Product Solution and Service
3.7 Date of Enter into Cough Suppressant Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cough Suppressant Drugs Breakdown Data by Type
4.1 Global Cough Suppressant Drugs Historic Market Size by Type (2019-2024)
4.2 Global Cough Suppressant Drugs Forecasted Market Size by Type (2025-2030)
5 Cough Suppressant Drugs Breakdown Data by Application
5.1 Global Cough Suppressant Drugs Historic Market Size by Application (2019-2024)
5.2 Global Cough Suppressant Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cough Suppressant Drugs Market Size (2019-2030)
6.2 North America Cough Suppressant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cough Suppressant Drugs Market Size by Country (2019-2024)
6.4 North America Cough Suppressant Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cough Suppressant Drugs Market Size (2019-2030)
7.2 Europe Cough Suppressant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cough Suppressant Drugs Market Size by Country (2019-2024)
7.4 Europe Cough Suppressant Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cough Suppressant Drugs Market Size (2019-2030)
8.2 Asia-Pacific Cough Suppressant Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cough Suppressant Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Cough Suppressant Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cough Suppressant Drugs Market Size (2019-2030)
9.2 Latin America Cough Suppressant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cough Suppressant Drugs Market Size by Country (2019-2024)
9.4 Latin America Cough Suppressant Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cough Suppressant Drugs Market Size (2019-2030)
10.2 Middle East & Africa Cough Suppressant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cough Suppressant Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Cough Suppressant Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perrigo Company
11.1.1 Perrigo Company Company Detail
11.1.2 Perrigo Company Business Overview
11.1.3 Perrigo Company Cough Suppressant Drugs Introduction
11.1.4 Perrigo Company Revenue in Cough Suppressant Drugs Business (2019-2024)
11.1.5 Perrigo Company Recent Development
11.2 Vernalis
11.2.1 Vernalis Company Detail
11.2.2 Vernalis Business Overview
11.2.3 Vernalis Cough Suppressant Drugs Introduction
11.2.4 Vernalis Revenue in Cough Suppressant Drugs Business (2019-2024)
11.2.5 Vernalis Recent Development
11.3 Tris Pharma
11.3.1 Tris Pharma Company Detail
11.3.2 Tris Pharma Business Overview
11.3.3 Tris Pharma Cough Suppressant Drugs Introduction
11.3.4 Tris Pharma Revenue in Cough Suppressant Drugs Business (2019-2024)
11.3.5 Tris Pharma Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Cough Suppressant Drugs Introduction
11.4.4 Pfizer Revenue in Cough Suppressant Drugs Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Acella Pharmaceuticals
11.5.1 Acella Pharmaceuticals Company Detail
11.5.2 Acella Pharmaceuticals Business Overview
11.5.3 Acella Pharmaceuticals Cough Suppressant Drugs Introduction
11.5.4 Acella Pharmaceuticals Revenue in Cough Suppressant Drugs Business (2019-2024)
11.5.5 Acella Pharmaceuticals Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Cough Suppressant Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Cough Suppressant Drugs Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
